Thomas Leung
2019
In 2019, Thomas Leung earned a total compensation of $2.4M as Former Chief Financial Officer at Avalanche Biotechnologies.
Compensation breakdown
Non-Equity Incentive Plan | $117,508 |
---|---|
Option Awards | $2,064,105 |
Salary | $253,782 |
Total | $2,435,395 |
Leung received $2.1M in option awards, accounting for 85% of the total pay in 2019.
Leung also received $117.5K in non-equity incentive plan and $253.8K in salary.
Rankings
In 2019, Thomas Leung's compensation ranked 4,978th out of 13,971 executives tracked by ExecPay. In other words, Leung earned more than 64.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,978 out of 13,971 | 64th |
Division Manufacturing | 1,852 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 653 out of 2,200 | 70th |
Industry group Drugs | 551 out of 1,886 | 71st |
Industry Biological Products, Except Diagnostic Substances | 124 out of 389 | 68th |
Source: SEC filing on April 26, 2022.
Leung's colleagues
We found two more compensation records of executives who worked with Thomas Leung at Avalanche Biotechnologies in 2019.